BANK OF MONTREAL /CAN/ - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2017$66,000
-43.1%
24,212
-17.2%
0.00%
Q2 2017$116,000
-3.3%
29,2280.0%0.00%
Q1 2017$120,000
-97.1%
29,228
-95.3%
0.00%
-100.0%
Q4 2014$4,118,000
-45.8%
616,430
-26.9%
0.01%
-44.4%
Q3 2014$7,592,000
-18.0%
843,578
+3.0%
0.01%
-10.0%
Q2 2014$9,253,000
-0.7%
818,831
+32.6%
0.01%
-16.7%
Q1 2014$9,319,000617,5470.01%
Other shareholders
CANCER GENETICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,391,607$1,239,0000.75%
PERKINS CAPITAL MANAGEMENT INC 1,004,550$894,0000.64%
Fairbanks Capital Management, Inc. 234,170$208,0000.24%
DIKER MANAGEMENT LLC 64,365$57,0000.02%
Granahan Investment Management 276,417$246,0000.02%
WEDBUSH SECURITIES INC 52,310$47,0000.01%
Court Place Advisors, LLC 10,000$9,0000.00%
SeaCrest Wealth Management, LLC 11,000$10,0000.00%
Renaissance Technologies 1,068,700$1,317,0000.00%
PANAGORA ASSET MANAGEMENT INC 43,664$39,0000.00%
View complete list of CANCER GENETICS INC shareholders